To investigate the cellular mechanisms by which the absence of IL-1β/IL-18, Casp-1, and Fpr-1 genes may attenuate the development of BOS inflammation, we also performed Western blot analyses for the mitogen-activated protein kinase (MAPK) pathway. The gene discussed is CASP1; the disease is Buschke-Ollendorff syndrome.